|
1
|
Jaggi AS and Singh N: Therapeutic targets
for the management of peripheral nerve injury-induced neuropathic
pain. CNS Neurol Disord Drug Targets. 10:589–609. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mukherjee P, Cinelli MA, Kang S and
Silverman RB: Development of nitric oxide synthase inhibitors for
neurodegeneration and neuropathic pain. Chem Soc Rev. 43:6814–6838.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sisignano M, Baron R, Scholich K and
Geisslinger G: Mechanism-based treatment for chemotherapy-induced
peripheral neuropathic pain. Nat Rev Neurol. 10:694–707. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Attal N, Cruccu G, Baron R, Haanpää M,
Hansson P, Jensen TS and Nurmikko T: European Federation of
Neurological Societies: EFNS guidelines on the pharmacological
treatment of neuropathic pain: 2010 revision. Eur J Neurol.
17:1113–1188. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Costigan M, Scholz J and Woolf CJ:
Neuropathic pain: A maladaptive response of the nervous system to
damage. Annu Rev Neurosci. 32:1–32. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bouhassira D, Lantéri-Minet M, Attal N,
Laurent B and Touboul C: Prevalence of chronic pain with
neuropathic characteristics in the general population. Pain.
136:380–387. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gilron I, Baron R and Jensen T:
Neuropathic Pain: Principles of diagnosis and treatment. Mayo
Clinic Proc. 90:532–545. 2015. View Article : Google Scholar
|
|
8
|
Rajamani U and Jialal I: Hyperglycemia
induces Toll-like receptor-2 and −4 expression and activity in
human microvascular retinal endothelial cells: Implications for
diabetic retinopathy. J Diabetes Res. 2014:7909022014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Madhumitha H, Mohan V, Kumar NP, Pradeepa
R, Babu S and Aravindhan V: Impaired toll-like receptor signalling
in peripheral B cells from newly diagnosed type-2 diabetic
subjects. Cytokine. 76:253–259. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu Y, Jiang Z, Huang J, Meng Q, Coh P and
Tao L: The association between toll-like receptor 4 polymorphisms
and diabetic retinopathy in Chinese patients with type 2 diabetes.
Br J Ophthalmol. 99:1301–1305. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nicotra L, Loram LC, Watkins LR and
Hutchinson MR: Toll-like receptors in chronic pain. Exp Neurol.
234:316–329. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao M, Li CH and Liu YL: Toll-like
receptor (TLR)-2/4 expression in retinal ganglion cells in a
high-glucose environment and its implications. Genet Mol Res.
15:2016.
|
|
13
|
Kim D, Kim MA, Cho IH, Kim MS, Lee S, Jo
EK, Choi SY, Park K, Kim JS, Akira S, et al: A critical role of
toll-like receptor 2 in nerve injury-induced spinal cord glial cell
activation and pain hypersensitivity. J Biol Chem. 282:14975–14983.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bettoni I, Comelli F, Rossini C, Granucci
F, Giagnoni G, Peri F and Costa B: Glial TLR4 receptor as new
target to treat neuropathic pain: Efficacy of a new receptor
antagonist in a model of peripheral nerve injury in mice. Glia.
56:1312–1319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang Q, Wu Q, Jiang J, Duan J, Wang C,
Smith MD, Lu H, Wang Q, Nagarkatti P and Fan D: Characterization of
sparstolonin B, a Chinese herb-derived compound, as a selective
Toll-like receptor antagonist with potent anti-inflammatory
properties. J Biol Chem. 286:26470–26479. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Q, Li J, Liang Q, Wang D, Luo Y, Yu F,
Janicki JS and Fan D: Sparstolonin B suppresses rat vascular smooth
muscle cell proliferation, migration, inflammatory response and
lipid accumulation. Vascul Pharmacol. 67–69:59–66. 2015. View Article : Google Scholar
|
|
17
|
Wang M, Xiu L, Diao J, Wei L and Sun J:
Sparstolonin B inhibits lipopolysaccharide-induced inflammation in
3T3-L1 adipocytes. Eur J Pharmacol. 769:79–85. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Q, Wang J, Liang Q, Wang D, Luo Y, Li
J, Janicki JS and Fan D: Sparstolonin B attenuates
hypoxia-reoxygenation-induced cardiomyocyte inflammation. Exp Biol
Med (Maywood). 239:376–384. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zimmermann M: Ethical guidelines for
investigations of experimental pain in conscious animals. Pain.
16:109–110. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu S, Zhu B, Sun Y and Xie X: MiR-155
modulates the progression of neuropathic pain through targeting
SGK3. Int J Clin Exp Pathol. 8:14374–14382. 2015.PubMed/NCBI
|
|
21
|
Zhou Z, Liang Y, Deng F, Cheng Y, Sun J,
Guo L and Xu G: Phosphorylated neuronal nitric oxide synthase in
neuropathic pain in rats. Int J Clin Exp Pathol. 8:12748–12756.
2015.PubMed/NCBI
|
|
22
|
Zhang J, Zou N, Liang Q, Tang Y and Duan
JA: Simultaneous HPLC quantitative analysis of nine bioactive
constituents in Scirpus Yagara Ohwi (Cyperaceae). J Chromatogr Sci.
54:453–459. 2016.PubMed/NCBI
|
|
23
|
Schefe JH, Lehmann KE, Buschmann IR, Unger
T and Funke-Kaiser H: Quantitative real-time RT-PCR data analysis:
Current concepts and the novel ‘gene expression's CT difference’
formula. J Mol Med (Berl). 84:901–910. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dworkin RH, Turk DC, Katz NP, Rowbotham
MC, Peirce-Sandner S, Cerny I, Clingman CS, Eloff BC, Farrar JT,
Kamp C, et al: Evidence-based clinical trial design for chronic
pain pharmacotherapy: A blueprint for ACTION. Pain. 152 Suppl
3:S107–S115. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kawasaki Y, Zhang L, Cheng JK and Ji RR:
Cytokine mechanisms of central sensitization: Distinct and
overlapping role of interleukin-1beta, interleukin-6, and tumor
necrosis factor-alpha in regulating synaptic and neuronal activity
in the superficial spinal cord. J Neurosci. 28:5189–5194. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Manning DC: New and emerging
pharmacological targets for neuropathic pain. Curr Pain Headache
Rep. 8:192–198. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Smith JA, Das A, Ray SK and Banik NL: Role
of pro-inflammatory cytokines released from microglia in
neurodegenerative diseases. Brain Res Bull. 87:10–20. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi XQ, Zekki H and Zhang J: The role of
TLR2 in nerve injury-induced neuropathic pain is essentially
mediated through macrophages in peripheral inflammatory response.
Glia. 59:231–241. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu FX, Bian JJ, Miao XR, Huang SD, Xu XW,
Gong DJ, Sun YM, Lu ZJ and Yu WF: Intrathecal siRNA against
Toll-like receptor 4 reduces nociception in a rat model of
neuropathic pain. Int J Med Sci. 7:251–259. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jurga AM, Rojewska E, Piotrowska A, Makuch
W, Pilat D, Przewlocka B and Mika J: Blockade of toll-like
receptors (TLR2, TLR4) attenuates pain and potentiates
buprenorphine analgesia in a rat neuropathic pain model. Neural
Plast. 2016:52387302016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Y, Zhang Y, Miao J, Hanley G, Stuart
C, Sun X, Chen T and Yin D: Chronic restraint stress promotes
immune suppression through toll-like receptor 4-mediated
phosphoinositide 3-kinase signaling. J Neuroimmunol. 204:13–19.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Blich M, Golan A, Arvatz G, Sebbag A,
Shafat I, Sabo E, Cohen-Kaplan V, Petcherski S, Avniel-Polak S,
Eitan A, et al: Macrophages activation by heparanase is mediated by
TLR-2 and TLR-4 and associates with plaque progression.
Arterioscler Thromb Vasc Biol. 33:e56–e65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Verstrepen L, Bekaert T, Chau TL,
Tavernier J, Chariot A and Beyaert R: TLR-4, IL-1R and TNF-R
signaling to NF-kappaB: Variations on a common theme. Cell Mol Life
Sci. 65:2964–2978. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Palová-Jelínková L, Dáňová K, Drašarová H,
Dvořák M, Funda DP, Fundová P, Kotrbová-Kozak A, Černá M, Kamanová
J, Martin SF, et al: Pepsin digest of wheat gliadin fraction
increases production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-κB
signaling pathway and an NLRP3 inflammasome activation. PLoS One.
8:e624262013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal
T, Junger W, Brohi K, Itagaki K and Hauser CJ: Circulating
mitochondrial DAMPs cause inflammatory responses to injury. Nature.
464:104–107. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cao H and Zhang YQ: Spinal glial
activation contributes to pathological pain states. Neurosci
Biobehav Rev. 32:972–983. 2008. View Article : Google Scholar : PubMed/NCBI
|
